Health Trials

Carcinoma, Non-Small Cell Lung Cancer (NSCLC)

2

Review clinical trials related to Carcinoma, Non-Small Cell Lung Cancer (NSCLC). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

An Adjuvant Study to Evaluate SMS001 (Paclitaxel) in Non-Small Cell Lung Cancer

This study evaluates the use of SMS001 in patients with lung cancer. SMS001 is a new form of drug Paclitaxel. Doctors want to decide an appropriate safe dose for SMS001 administration, and to see how well it works in treating lung cancer patients.

Participants needed: 42
Trial details
Phase: Phase 2Age: 18-80Biological sex: AllType: InterventionalSponsor: ToLymph Inc.Updated: Mar 6, 2026Locations: 2
Eligibility criteria

Histopathological confirmed NSCLC [+18]

Evidence of locally advanced T3 or T4 NSCLC or distant metastatic disease. [+8]

Read more
Status: Recruiting

IBI363 (PD-1/IL-2α-bias) in Combination With Chemotherapy as Neoadjuvant Therapy in Initially Unresectable Stage III Non-Small Cell Lung Cancer

This study is a single-arm, phase II clinical trial evaluating the safety and efficacy of IBI363 combined with chemotherapy as a neoadjuvant treatment of non-small cell lung cancer.

Participants needed: 43
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Shanghai Pulmonary Hospital, Shanghai, ChinaUpdated: Feb 13, 2026Locations: 1
Eligibility criteria

The patient shall sign the informed consent. [+15]

Non-squamous and squamous NSCLC with EGFR active mutation positive, ALK rearrang... [+18]

Read more